Health care expiration dating policy
Scientifically accepted infection control techniques include but are not limited to A chain of events is required for infection to occur.These events are a causative organism, a reservoir for the organism, a means to exit the reservoir, a mode of transmission, a susceptible host, and a mode of entry into the host.
The only effective antibiotic for treating these infections is vancomycin.Pregnant healthcare professionals are not known to be at greater risk of contracting bloodborne infections; however, during pregnancy, the infant is at risk of perinatal transmission.The organism must have a portal of entry into the host for infection to occur.Methicillin- and oxacillin-resistant colonization are rarely recognized and MRSA colonization is quite common, so every patient must be assumed to have been exposed to and/or colonized with MRSA/ORSA.In addition, MRSA often contaminates medical equipment such as stethoscopes and environmental surfaces like computer keyboards.Causative organisms may be bacteria, rickettsiae, viruses, protozoa, fungi, or parasites.
The characteristics of causative organisms are: The organism and its reservoir are the sources of infection.
Portals of entry are the mucous membranes, non-intact skin, respiratory tract, gastrointestinal tract, genitourinary tracts, or a mechanism of introduction (percutaneous injury or invasive devices).
All of the microorganisms that can cause disease are capable of developing resistance to antibiotics and other drugs that are used to treat infections caused by these pathogens.
In New York, state rules and regulations define responsibility for compliance and consequences for non-compliance with infection control practices.
All licensed healthcare facilities are responsible for monitoring and enforcing proper use of infection control practices and Standard Precautions.
Antibiotic-resistant organisms have become an increasingly serious problem, and some of the more common ones are discussed. Carbapenem-resistant enterobacteriaceae (CRE) are resistant to treatment with the carbapenem family of antibiotics (Doripenem, ertapenem, imipenem, and meropenem), the antibiotics that have traditionally been used to treat pathogens that are resistant to broad-spectrum antimicrobials.